Cerebrospinal fluid xanthochromia after pegasparaginase hepatotoxicity in B-cell acute lymphoblastic leukemia
Riccardo Moia1, Mariangela Greco1, Paola Boggione1
1Division of Hematology Department of Translational Medicine Università del Piemonte Orientale Novara Italy.
Clinical Case Reports
|November 25, 2020
Abstract:
Patients with B-lineage acute lymphoblastic leukemia treated with pegasparaginase-containing regimens can develop hepatotoxicity related to it. The systemic hyperbilirubinemia due to hepatotoxicity can lead to the development of CSF xanthochromia.


